Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Electromed Inc receives FDA market clearance for SmartVest SQL


Monday, 30 Dec 2013 09:00am EST 

Electromed Inc:Says it has received notification from the U.S. Food and Drug Administration that its SmartVest Airway Clearance System, the model SQL has been cleared to market.Says the model SQL is an electrically powered precursor device designed to deliver chest wall oscillation (HFCWO) to promote airway clearance, improve bronchial drainage and enhance mucus transport under the order of a physician`s prescription. 

Company Quote

1.49
0.0 +0.00%
22 Jul 2014